PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA. Huskamp@hcp.med.harvard.edu.\', \'Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA.\', \'RAND Corporation, Arlington, VA, USA.\', \'McLean Hospital, Belmont, MA, USA.\', \'Department of Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.\', \'Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women\'s Hospital, Boston, MA, USA.\', \'Greater Los Angeles VA Medical Center, Los Angeles, CA, USA.\', \'Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11606-021-07174-w
?:hasPublicationType
?:journal
  • Journal of general internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34713386
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.612
?:rankingScore_hIndex
  • 155
?:title
  • Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all